GB1590155A - Cis-4a-phenyl-2,3,4,4a,5,6,7,7a-octahydro-1h-2-pyrindines and pharmaceutical compositions containing them - Google Patents

Cis-4a-phenyl-2,3,4,4a,5,6,7,7a-octahydro-1h-2-pyrindines and pharmaceutical compositions containing them Download PDF

Info

Publication number
GB1590155A
GB1590155A GB44729/77A GB4472977A GB1590155A GB 1590155 A GB1590155 A GB 1590155A GB 44729/77 A GB44729/77 A GB 44729/77A GB 4472977 A GB4472977 A GB 4472977A GB 1590155 A GB1590155 A GB 1590155A
Authority
GB
United Kingdom
Prior art keywords
octahydro
pyrindine
compound
formula
hydroxyphenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB44729/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of GB1590155A publication Critical patent/GB1590155A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/757—Unsaturated compounds containing a keto groups being part of a ring containing —CHO groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
GB44729/77A 1976-11-02 1977-10-27 Cis-4a-phenyl-2,3,4,4a,5,6,7,7a-octahydro-1h-2-pyrindines and pharmaceutical compositions containing them Expired GB1590155A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73795876A 1976-11-02 1976-11-02

Publications (1)

Publication Number Publication Date
GB1590155A true GB1590155A (en) 1981-05-28

Family

ID=24965981

Family Applications (1)

Application Number Title Priority Date Filing Date
GB44729/77A Expired GB1590155A (en) 1976-11-02 1977-10-27 Cis-4a-phenyl-2,3,4,4a,5,6,7,7a-octahydro-1h-2-pyrindines and pharmaceutical compositions containing them

Country Status (26)

Country Link
JP (1) JPS5356669A (nl)
AR (1) AR223454A1 (nl)
AT (1) ATA782177A (nl)
AU (1) AU513679B2 (nl)
BE (1) BE860314A (nl)
CA (1) CA1100136A (nl)
CS (1) CS211380B2 (nl)
DD (1) DD133795A5 (nl)
DE (1) DE2748466A1 (nl)
DK (1) DK485277A (nl)
ES (3) ES463784A1 (nl)
FR (1) FR2369267A1 (nl)
GB (1) GB1590155A (nl)
GR (1) GR70053B (nl)
HU (1) HU176231B (nl)
IE (1) IE45901B1 (nl)
IL (1) IL53236A0 (nl)
NL (1) NL7712053A (nl)
NZ (1) NZ185539A (nl)
PH (1) PH12590A (nl)
PL (3) PL108610B1 (nl)
PT (1) PT67194B (nl)
RO (3) RO77935A (nl)
SE (3) SE7712218L (nl)
SU (3) SU812174A3 (nl)
ZA (1) ZA776497B (nl)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8598164B2 (en) 2010-05-06 2013-12-03 Vertex Pharmaceuticals Incorporated Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
US8828996B2 (en) 2011-03-14 2014-09-09 Vertex Pharmaceuticals Incorporated Morpholine-spirocyclic piperidine amides as modulators of ion channels
US8916565B2 (en) 2011-02-02 2014-12-23 Vertex Pharmaceuticals Incorporated Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
US10385070B2 (en) 2011-02-18 2019-08-20 Vertex Pharmaceuticals Incorporated Chroman-spirocyclic piperidine amides as modulators of ion channels

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL117572B1 (en) * 1977-12-27 1981-08-31 Lilly Co Eli Process for preparing novel derivatives of trans-4a-phenyl-2,3,4,4a,5,6,7,7a-octahydro-1h-2-pyrindine3,4,4a,5,6,7,7a-oktagidro-1h-2-piridina
US4277608A (en) * 1979-06-21 1981-07-07 Eli Lilly And Company Method of preparing 4a-arylhexahydro-1H-2-pyrindines and 4a-aryloctahydroisoquinolines
US4236009A (en) * 1979-06-21 1980-11-25 Eli Lilly And Company Method of preparing 4A-arylhexahydro-1H-2-pyrindines and 4A-aryloctahydroisoquinolines
ZA9510829B (en) * 1994-12-23 1996-07-03 Smithkline Beecham Corp 3,3-(disubstituted)cyclohexan-1-one monomers and related compounds

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8598164B2 (en) 2010-05-06 2013-12-03 Vertex Pharmaceuticals Incorporated Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
US8916565B2 (en) 2011-02-02 2014-12-23 Vertex Pharmaceuticals Incorporated Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
US9511067B2 (en) 2011-02-02 2016-12-06 Vertex Pharmaceuticals Incorporated Substituted spiro[piperidine-4,1'-pyrrolo[1,2-a]pyrazine]s as modulators of ion channels
US10385070B2 (en) 2011-02-18 2019-08-20 Vertex Pharmaceuticals Incorporated Chroman-spirocyclic piperidine amides as modulators of ion channels
US8828996B2 (en) 2011-03-14 2014-09-09 Vertex Pharmaceuticals Incorporated Morpholine-spirocyclic piperidine amides as modulators of ion channels
US9181273B2 (en) 2011-03-14 2015-11-10 Vertex Pharmaceuticals Incorporated Morpholine-spirocyclic piperidine amides as modulators of ion channels

Also Published As

Publication number Publication date
PL108466B1 (en) 1980-04-30
BE860314A (fr) 1978-04-28
IE45901L (en) 1978-05-02
PL109690B1 (en) 1980-06-30
JPS5356669A (en) 1978-05-23
SU845777A3 (ru) 1981-07-07
RO72900A (ro) 1981-11-04
PH12590A (en) 1979-06-27
PL201885A1 (pl) 1978-12-04
DE2748466A1 (de) 1978-05-03
HU176231B (en) 1981-01-28
DD133795A5 (de) 1979-01-24
FR2369267A1 (fr) 1978-05-26
IE45901B1 (en) 1982-12-29
SE8103107L (sv) 1981-05-18
RO78300A (ro) 1982-04-12
FR2369267B1 (nl) 1980-05-16
ES472276A1 (es) 1979-10-01
IL53236A0 (en) 1977-12-30
ZA776497B (en) 1979-06-27
AR223454A1 (es) 1981-08-31
AU513679B2 (en) 1980-12-18
ATA782177A (de) 1981-10-15
ES463783A1 (es) 1979-07-16
SU812174A3 (ru) 1981-03-07
PT67194A (en) 1977-11-01
PT67194B (en) 1979-03-23
AU3023577A (en) 1979-05-10
GR70053B (nl) 1982-07-26
SU913941A3 (en) 1982-03-15
NL7712053A (nl) 1978-05-05
RO77935A (ro) 1981-12-25
PL108610B1 (en) 1980-04-30
CA1100136A (en) 1981-04-28
SE8103106L (sv) 1981-05-18
ES463784A1 (es) 1978-06-16
CS211380B2 (en) 1982-02-26
NZ185539A (en) 1979-12-11
DK485277A (da) 1978-05-03
SE7712218L (sv) 1978-05-02

Similar Documents

Publication Publication Date Title
US4337341A (en) 4a-Aryl-octahydro-1H-2-pyrindines
DK160501B (da) Substituerede benzoatestere af 3-hydroxymorphinaner samt farmaceutiske praeparater indeholdende saadanne
GB2145416A (en) Benzoic acid derivatives
JPWO2002074746A1 (ja) ベンゾアゼピン誘導体
US4374139A (en) Levorotatory N-substituted acylmorphinans useful as analgesic agents
JPS61271275A (ja) モルヒナン誘導体
US4001248A (en) N-cycloalkylmethyl decahydroisoquinolines
US4132709A (en) [2]Benzopyrano[4,3-c]pyridine derivatives and process therefor
GB1590155A (en) Cis-4a-phenyl-2,3,4,4a,5,6,7,7a-octahydro-1h-2-pyrindines and pharmaceutical compositions containing them
EP0028717B1 (en) 6,7-benzomorphan derivatives, processes for their production, pharmaceutical compositions containing said derivatives and their use as pharmaceuticals
WO1990012574A1 (en) Dopamine agonist compounds
US4001247A (en) 1-ethyl 3a-(substituted-phenyl) decahydroisoquinoline
US3513169A (en) 5,9-diethyl benzomorphan derivatives
CA1105026A (en) 4a-aryl-octahydro-1h-2-pyrindines
ES2311034T3 (es) Derivados de indol y uso de los mismos en medicamentos.
US3499906A (en) 5,9-diethyl-2'-hydroxy-2-substituted-6,7-benzomorphans
EP0299549A2 (en) Tertiary 2,5-dialkyl-3-phenyl-piperidine derivatives having opiate-antagonistic activity
WO1990001025A1 (en) Enamine quaternary compounds, methods of making and their use as muscle relaxants
EP0018077A2 (en) Phenylmorphans, processes for their preparation and pharmaceutical compositions containing them
CA1119175A (en) 4a-aryl octahydro-1h-2-pyrindines
Sober et al. Selective and potent. beta. 2-adrenoceptor agents within the tetrahydroisoquinoline class: effect of methyl substitution at the benzylic carbon of the 1-(3, 4, 5-trimethoxybenzyl) group of trimetoquinol
KR810000583B1 (ko) 4a-아릴-옥타하이드로-1H-2-피린딘류의 제조방법
US4278797A (en) Intermediates to phenylmorphans and method of preparation thereof
US4141894A (en) Trans-5a-aryl-decahydrobenzazepines
GB1594687A (en) 2-aminotetralin derivatives and processes for producing the same

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PCNP Patent ceased through non-payment of renewal fee